Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1873 - 1880 of 11617 results
Has Big Law Hit Peak Empathy?
July 29, 2022| News
PAMA Laboratory Reporting In Flux: ACLA Wins HHS Lawsuit and Congress Introduces PAMA Amendment Legislation
July 29, 2022| Blog| Viewpoint
Potential Pitfalls of Telehealth Prescribing
July 29, 2022| News
Reconciliation Bill Expands, But Muni Priorities Still Left Out
July 28, 2022| News
The ITC Should Put Its Foot Down on Patent Holdout and Holdup
July 27, 2022| News
Time to Evaluate Your Filer Status for Next Year
July 26, 2022| Advisory| Viewpoint
EEOC Updates Screening, Testing, and Mandatory Vaccination Policies
July 26, 2022| Blog| Viewpoint
New York Office of Medicaid Inspector General Proposes Regulations on Medicaid Provider Compliance Programs
July 26, 2022| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.